Interview: Mike Harsh on the evolution of Imaging and Imagion’s role
With over 40 years’ experience in the health care diagnostic imaging industry, Imagion Biosystems (ASX:IBX) Board member Mike Harsh is one of the world’s most qualified people to speak about the evolution of diagnostics.
Finfeed‘s Jonathan Jackson sat down with a very enthusiastic Harsh to discuss the industry, the limited ways to image the human body (X-ray, CT, MRI, ultrasound, and PET/SPECT) and how Imagion is reimagining the process.
Read the interview.
Highlights Blinded review by panel of expert breast radiologists corroborates potential for MagSense® nanoparticle technology to detect tumour cells in lymph nodes by Magnetic Resonance